Stay updated on Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.

Latest updates to the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page
- Check4 days agoChange DetectedThe page revision was bumped from v3.5.4 to v3.5.5 as a minor maintenance update. This does not alter the study details or other user-facing content.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision label changed from v3.5.3 to v3.5.4. This update does not modify study details or data presented on the page.SummaryDifference0.0%

- Check47 days agoChange DetectedA location spelling is corrected so the Parramatta, New South Wales site name is consistent. The page’s revision/version label is updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision: v3.4.3 added; Revision: v3.4.2 removed.SummaryDifference0.0%

Stay in the know with updates to Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.